Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|health policy

    #660191

    IATE #3578833
    praghsáil tagartha Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    córas praghsála tagartha Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Tar éis thosach feidhm an Achta Sláinte (Earraí Liachta a Phraghsáil agus a Sholáthar) i Meitheamh 2013, cuireadh de chúram ar ÚRTS liosta de chógais inmhalartaithe a fhoilsiú d’fhonn a urasú do chógaiseoirí cógais chineálacha a mhalartú agus chun go bhféadfadh FSS córas praghsála tagartha a thabhairt isteach.' Reference "'Tuarascáil Bhliantúil 2014,' an tÚdarás Rialála Táirgí Sláinte, https://www.hpra.ie/docs/default-source/publications-forms/corporate-policy-documents/tuarasc%C3%A1il-bhliant%C3%BAil-2014%20.pdf?sfvrsn=10 [14.1.2019]"
    Referenzpreissystem
    de
    reference pricing system | reference pricing
    en
    Definition system that establishes a reimbursement level or reference price for a group of interchangeable medicines Reference "Pieter Dylst, Arnold G Vulto, Steven Simoens. Reference pricing systems in Europe: characteristics and consequences. Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4):127-31, http://gabi-journal.net/reference-pricing-systems-in-europe-characteristics-and-consequences.html [9.10.2018]"
    Comment "If a medicine is priced above the reference price, the patient pays the difference between the price of the medicine and the reference price, in addition to any other co-payments, e.g. prescription fee, percentage co-payment. Reference: Pieter Dylst, Arnold G Vulto, Steven Simoens. Reference pricing systems in Europe: characteristics and consequences. Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4):127-31, http://gabi-journal.net/reference-pricing-systems-in-europe-characteristics-and-consequences.html [9.10.2018]"
    système de prix de référence
    fr
    Definition système de prix limitant le remboursement des médicaments en fixant un niveau maximum de remboursement pour un groupe de spécialités pharmaceutiques, toute différence entre le prix de référence et le prix d’un médicament plus onéreux devant être payée par le patient Reference "COM-FR d'après: Centre fédéral d’expertise des soins de santé - Le système du prix de référence et les différences socio-économiques dans l’utilisation des médicaments moins onéreux - KCE reports 126B [2010] https://kce.fgov.be/sites/default/files/atoms/files/d20101027319.pdf [13.11.2018]"